NCT06959966View on ClinicalTrials.gov

Effects of Oligo-fucoidan on Leiomyoma Patients

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 14, 2019

Primary Completion Date

December 1, 2022

Study Completion Date

January 31, 2023

Conditions
Uterine Leiomyoma
Interventions
COMBINATION_PRODUCT

Placebo

Starch capsule, 4 grams, two capsules per day for six months.

COMBINATION_PRODUCT

Oligo Fucoidan

Oligo fucoidan capsule, 4 grams, two capsules per day for six months.

Trial Locations (1)

110

Taipei Medical Univeersity, Taipei

All Listed Sponsors
collaborator

Hi-Q Marine Biotech International, Ltd.

INDUSTRY

lead

Taipei Medical University

OTHER

NCT06959966 - Effects of Oligo-fucoidan on Leiomyoma Patients | Biotech Hunter | Biotech Hunter